|
End-of-day quote
Shenzhen S.E.
2026-11-18
|
5-day change | 1st Jan Change | ||
| 11.22 CNY | -1.41% |
|
-5.24% | -16.14% |
| Market Cap | 2.61B 391M 357M 330M 298M 561M 36.57B 583M 3.99B 1.58B 19.74B 1.47B 1.44B 62.32B | P/E 2026 * |
13.7x | P/E 2027 * | 12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.61B 391M 357M 330M 298M 561M 36.57B 583M 3.99B 1.58B 19.74B 1.47B 1.44B 62.32B | EV / Sales 2026 * |
2.55x | EV / Sales 2027 * | 2.3x |
| Free-Float |
59.64% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.41% | ||
| 1 week | -5.24% | ||
| Current month | -0.97% | ||
| 1 month | -11.23% | ||
| 3 months | -14.48% | ||
| 6 months | -16.58% | ||
| Current year | -16.14% |
| 1 week | 11.18 | 11.85 | |
| 1 month | 11.04 | 12.88 | |
| Current year | 11.04 | 17.14 | |
| 1 year | 11.04 | 17.14 | |
| 3 years | 9.92 | 17.14 | |
| 5 years | 9.68 | 21.53 | |
| 10 years | 6.93 | 24.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dao Cai Song
CEO | Chief Executive Officer | 57 | 2024-08-01 |
Qi Liu
DFI | Director of Finance/CFO | 54 | 2020-06-22 |
Chuan Zhen Wang
AUD | Comptroller/Controller/Auditor | 38 | 2006-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Dao Cai Song
BRD | Director/Board Member | 57 | 2018-08-02 |
Han Fang Lei
BRD | Director/Board Member | 45 | 2020-07-30 |
Ping Lin
BRD | Director/Board Member | 62 | 2021-08-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/3/20 | Sell | Chief Financial Officer | 5,000 | 0.0035% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.41% | -5.24% | -18.81% | -26.52% | 397M | ||
| -2.32% | -3.79% | +34.24% | +133.69% | 1,261B | ||
| -2.15% | -2.75% | +36.35% | +82.05% | 671B | ||
| -2.33% | -3.04% | +22.29% | +106.80% | 518B | ||
| -0.69% | +0.37% | +31.53% | +69.78% | 387B | ||
| -3.90% | -6.39% | +42.88% | +35.41% | 353B | ||
| -1.35% | -0.95% | +28.90% | +56.34% | 300B | ||
| -1.13% | -1.80% | +0.59% | +33.00% | 283B | ||
| -3.07% | -5.17% | +29.04% | +67.26% | 248B | ||
| -0.75% | -0.44% | +32.87% | +123.96% | 211B | ||
| Average | -1.91% | -2.09% | +23.99% | +68.18% | 423B | |
| Weighted average by Cap. | -2.09% | -2.34% | +30.58% | +91.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.02B 153M 140M 129M 117M 220M 14.32B 228M 1.56B 617M 7.73B 575M 563M 24.4B | 1.14B 170M 155M 143M 129M 244M 15.9B 253M 1.73B 685M 8.58B 638M 625M 27.1B |
| Net income | 192M 28.79M 26.25M 24.27M 21.9M 41.25M 2.69B 42.88M 293M 116M 1.45B 108M 106M 4.58B | 217M 32.53M 29.67M 27.43M 24.76M 46.63M 3.04B 48.46M 331M 131M 1.64B 122M 119M 5.18B |
| Net Debt | - | - |
Employees
1,130
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-18 | CN¥11.22 | -1.41% | 2,181,800 |
| 26-11-17 | CN¥11.38 | -0.70% | 2,189,300 |
| 26-11-16 | CN¥11.46 | -1.21% | 2,177,424 |
| 26-11-13 | CN¥11.60 | -1.28% | 2,581,100 |
| 26-11-12 | CN¥11.75 | -0.76% | 2,167,600 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
11.22CNY
Average target price
16.00CNY
Spread / Average Target
+42.60%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300452 Stock
Select your edition
All financial news and data tailored to specific country editions
















